Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Bacteriology comprises of reagents, and test kits to detect the pathogenicity of bacteria such as chlamydia, gonococci, syphilis, helicobacter pylori, salmonella and so on. The bacteriology pipeline market research report provides comprehensive information about the bacteriology pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bacteriology Pipeline Products Market Segments

The key segments in the bacteriology pipeline products market are Syphilis and Meningitiscausitive Agents. Syphilis have the highest number of products in the bacteriology pipeline products market.

Bacteriology Pipeline Products Market Analysis by Segments, 2022 (%)

Bacteriology Pipeline Products Market Analysis by SegmentsFor more insights into the bacteriology pipeline products market segments, download a free report sample

Bacteriology Pipeline Products Market Segmentation by Territories

Some of the key territories with bacteriology products in the pipeline are the United States, Europe, Global, India, Israel, Japan, Australia, Canada, the United Kingdom, and South Korea among others. As of November 2022, the US has the highest number of products in the pipeline out of them all.

Bacteriology Pipeline Products Market Analysis, by Territories, 2022 (%)

Bacteriology Pipeline Products Market Analysis, by TerritoriesFor more territory insights into the bacteriology pipeline products market, download a free report sample

Bacteriology Pipeline Products Market Segmentation by Regulatory Paths

Some of the key regulatory paths followed by the bacteriology pipeline products market are 510(k), CE-IVD, ICAC, PMA, CE, TGA, MDL, and MDITAC among others. Most of the products follow the 510(k) pathway to enter the market.

Bacteriology Pipeline Products Market Analysis, by Regulatory Paths, 2022 (%)

Bacteriology Pipeline Products Market Analysis, by Regulatory PathsFor more bacteriology pipeline products regulatory path insights, download a free report sample

Bacteriology Pipeline Products Market - Competitive Landscape

Some of the leading companies in the bacteriology pipeline products market are 3a-Diagnostics GmbH, Abacus Diagnostica Ltd, Adaltis Srl, Advanced Laboratory Services, INC., Akonni Biosystems Inc, Alere Inc, American Bio Medica Corp, Amity University, and Angle Biosciences Inc among others.

Bacteriology Pipeline Products Market Report Overview

Key Segments Syphilis and Meningitiscausitive Agents
Analysis Year 2022
Key Territories The United States, Europe, Global, India, Israel, Japan, Australia, Canada, the United Kingdom, and South Korea
Key Regulatory Paths 510(k), CE-IVD, ICAC, PMA, CE, TGA, MDL, and MDITAC
Leading Companies 3a-Diagnostics GmbH, Abacus Diagnostica Ltd, Adaltis Srl, Advanced Laboratory Services, INC., Akonni Biosystems Inc, Alere Inc, American Bio Medica Corp, Amity University, and Angle Biosciences Inc

Bacteriology Pipeline Products Market Segments Outlook (2022)

  • Syphilis
  • Meningitiscausitive Agents

Bacteriology Pipeline Products Market Territories Outlook (2022)

  • The United States
  • Europe
  • Global
  • India
  • Israel
  • Japan
  • Australia
  • Canada
  • The United Kingdom
  • South Korea

Bacteriology Pipeline Products Market Regulatory Paths Outlook (2022)

  • 510(k)
  • CE-IVD
  • ICAC
  • PMA
  • CE
  • TGA
  • MDL
  • MDITAC

Scope

This report provides:

  • Extensive coverage of the bacteriology under development.
  • Details of major bacteriology pipeline products which include product description, licensing, collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.
  • Reviews of the major players involved in the development of bacteriology and list all their pipeline projects.
  • The coverage of bacteriology pipeline products based on various stages of development ranging from early development to the approved/issued stage.
  • Key clinical trial data of ongoing trials specific to bacteriology pipeline products.
  • Recent Developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
  • Identify and understand important and diverse types of bacteriology under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3a-Diagnostics GmbH
Abacus Diagnostica Ltd
Adaltis Srl
Advanced Laboratory Services, INC.
Akonni Biosystems Inc
Alere Inc
American Bio Medica Corp
Amity University
Angle Biosciences Inc
Antigen Discovery Inc
Applied BioCode Inc
Ares Genetics GmbH
Aseptika Ltd
Astute Medical Inc
Asylia Diagnostics BV
Ayanda Biosystems SA (Inactive)
Beckman Coulter Inc
Biocartis Group NV
Biocrates Life Sciences AG
BioFilm Control SAS
BioHelix Corp
Biointerfaces Institute
Biois Corp
BioMaxima SA
bioMerieux SA
Biopeptide corp
BioSentinel Pharmaceuticals, Inc.
Biotechnology Assets SA
Bordeaux University Hospital
Brigham Young University Inc
C3J Therapeutics Inc (Inactive)
Calypte Biomedical Corporation
Carolina Liquid Chemistries Corp
CellCarta Biosciences Inc
Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
Cepheid Inc
Children's Hospital of Michigan
China Medical Technologies Inc (Inactive)
Co-Diagnostics Inc
Conrad
Coris BioConcept
Courtagen Life Sciences Inc
Cubed Laboratories LLC
Cupid Ltd
Daan Gene Co Ltd
Defence Science and Technology Laboratory
DIANA Biotechnologies SRO
DiaSorin SpA
DSX Therapeutics LLC
Ellume Ltd
Emory University
Enigma Diagnostics Ltd (Inactive)
EUROIMMUN US LLC
First Light Diagnostics Inc
FK-Biotecnologia SA
Focus Diagnostics Inc
Foundation for Innovative New Diagnostics
Fyodor Biotechnologies, Inc.
Genekam Biotechnology AG
Genome Diagnostics Pvt Ltd
GNA Biosolutions GmbH
Godx Inc
Great Basin Scientific Inc.
Guanine Inc
HAV Vaccines Ltd
HDT Biotech Corp
Health and Bliss (Inactive)
Helixbind Inc
Helmholtz Centre for Infection Research
HiberGene Diagnostics Ltd
Hutman Diagnostics AG
iCubate Inc
InBios International Inc
Innovative Biosensors, Inc.
InstantLabs Inc
Institute for Development Research
Jagiellonian University
Johns Hopkins University
Kaneka Corp
L2 Diagnostics LLC
Luminex Corp
Marx Biotechnology Ltd
Master Diagnostica Sociedad Limitada
Medica Corp
Meridian Bioscience Inc
MicroPhage Inc (Inactive)
Molecular Detection Inc (Inactive)
MyCartis NV
Mylab Discovery Solutions Pvt Ltd
Nanosphere Inc (Inactive)
National Cheng-Kung University Hospital
Naval Medical Research Center
NeuMoDx Molecular Inc
Newcastle University
North Carolina State University
Novartis AG
OpGen Inc
Optolane Technologies Inc
Pathogenica Inc
Pennsylvania State University
Pictor Ltd
PositiveID Corp
Presymptom Health Ltd
Proactive Oral Solutions, Inc.
ProCelo AS
Promyco Diagnostics Ltd (Inactive)
Qiagen NV
Quidel Corp
RedHill Biopharma Ltd
Renishaw Plc
Rheonix Inc
Roche Diagnostics International Ltd
Rockefeller University
Sansure Biotech Inc
Seegene Inc
Sex Positive Diagnostics
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Shenzhen New Industries Biomedical Engineering Co Ltd
SomaLogic Inc
Spanish National Research Council
SpeeDx Pty Ltd
TBG Diagnostics Ltd
The University of Nottingham
Tosoh Bioscience Inc
Transfusion & Transplantation Technologies (Inactive)
Trillium Diagnostics LLC (Inactive)
University at Buffalo
University of Calgary
University of California San Diego
University of California San Francisco
University of Cincinnati
University of Leicester
University of Liverpool
University of Maryland Baltimore
University of Melbourne
University of Michigan
University of Oxford
University of Pennsylvania
University of Strathclyde
University of Washington
University of Wisconsin Madison
Verax Biomedical Inc
Victory Square Health Inc
Yale University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 12

|1.2 List of Figures 25

2 Introduction 26

2.1 Bacteriology Overview 26

3 Products under Development 27

3.1 Bacteriology – Pipeline Products by Stage of Development 27

3.2 Bacteriology – Pipeline Products by Segment 28

3.3 Bacteriology – Pipeline Products by Territory 29

3.4 Bacteriology – Pipeline Products by Regulatory Path 30

3.5 Bacteriology – Pipeline Products by Estimated Approval Date 31

3.6 Bacteriology – Ongoing Clinical Trials 32

4 Bacteriology – Pipeline Products under Development by Companies 33

4.1 Bacteriology Companies – Pipeline Products by Stage of Development 33

4.2 Bacteriology – Pipeline Products by Stage of Development 39

5 Bacteriology Companies and Product Overview 46

5.1 3a-Diagnostics GmbH Company Overview 46

5.1.1 3a-Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 46

5.2 Abacus Diagnostica Ltd Company Overview 47

5.2.1 Abacus Diagnostica Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.3 Adaltis Srl Company Overview 48

5.3.1 Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 48

5.4 Advanced Laboratory Services, INC. Company Overview 61

5.4.1 Advanced Laboratory Services, INC. Pipeline Products & Ongoing Clinical Trials Overview 61

5.5 Akonni Biosystems Inc Company Overview 62

5.5.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.6 Alere Inc Company Overview 64

5.6.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.7 American Bio Medica Corp Company Overview 66

5.7.1 American Bio Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 66

5.8 Amity University Company Overview 67

5.8.1 Amity University Pipeline Products & Ongoing Clinical Trials Overview 67

5.9 Angle Biosciences Inc Company Overview 69

5.9.1 Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.10 Antigen Discovery Inc Company Overview 70

5.10.1 Antigen Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.11 Applied BioCode Inc Company Overview 71

5.11.1 Applied BioCode Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.12 Ares Genetics GmbH Company Overview 72

5.12.1 Ares Genetics GmbH Pipeline Products & Ongoing Clinical Trials Overview 72

5.13 Aseptika Ltd Company Overview 73

5.13.1 Aseptika Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

5.14 Astute Medical Inc Company Overview 74

5.14.1 Astute Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.15 Asylia Diagnostics BV Company Overview 75

5.15.1 Asylia Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview 75

5.16 Ayanda Biosystems SA (Inactive) Company Overview 76

5.16.1 Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76

5.17 Beckman Coulter Inc Company Overview 77

5.17.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.18 Biocartis Group NV Company Overview 79

5.18.1 Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview 79

5.19 Biocrates Life Sciences AG Company Overview 80

5.19.1 Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview 80

5.20 BioFilm Control SAS Company Overview 81

5.20.1 BioFilm Control SAS Pipeline Products & Ongoing Clinical Trials Overview 81

5.21 BioHelix Corp Company Overview 82

5.21.1 BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview 82

5.22 Biointerfaces Institute Company Overview 83

5.22.1 Biointerfaces Institute Pipeline Products & Ongoing Clinical Trials Overview 83

5.23 Biois Corp Company Overview 84

5.23.1 Biois Corp Pipeline Products & Ongoing Clinical Trials Overview 84

5.24 BioMaxima SA Company Overview 86

5.24.1 BioMaxima SA Pipeline Products & Ongoing Clinical Trials Overview 86

5.25 bioMerieux SA Company Overview 87

5.25.1 bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 87

5.26 Biopeptide corp Company Overview 89

5.26.1 Biopeptide corp Pipeline Products & Ongoing Clinical Trials Overview 89

5.27 BioSentinel Pharmaceuticals, Inc. Company Overview 90

5.27.1 BioSentinel Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90

5.28 Biotechnology Assets SA Company Overview 91

5.28.1 Biotechnology Assets SA Pipeline Products & Ongoing Clinical Trials Overview 91

5.29 Bordeaux University Hospital Company Overview 92

5.29.1 Bordeaux University Hospital Pipeline Products & Ongoing Clinical Trials Overview 92

5.30 Brigham Young University Inc Company Overview 93

5.30.1 Brigham Young University Inc Pipeline Products & Ongoing Clinical Trials Overview 93

5.31 C3J Therapeutics Inc (Inactive) Company Overview 94

5.31.1 C3J Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 94

5.32 Calypte Biomedical Corporation Company Overview 96

5.32.1 Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview 96

5.33 Carolina Liquid Chemistries Corp Company Overview 97

5.33.1 Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 97

5.34 CellCarta Biosciences Inc Company Overview 99

5.34.1 CellCarta Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.35 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Company Overview 100

5.35.1 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview 100

5.36 Cepheid Inc Company Overview 102

5.36.1 Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 102

5.37 Children’s Hospital of Michigan Company Overview 112

5.37.1 Children’s Hospital of Michigan Pipeline Products & Ongoing Clinical Trials Overview 112

5.38 China Medical Technologies Inc (Inactive) Company Overview 113

5.38.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 113

5.39 Co-Diagnostics Inc Company Overview 114

5.39.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 114

5.40 Conrad Company Overview 115

5.40.1 Conrad Pipeline Products & Ongoing Clinical Trials Overview 115

5.41 Coris BioConcept Company Overview 116

5.41.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 116

5.42 Courtagen Life Sciences Inc Company Overview 117

5.42.1 Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 117

5.43 Cubed Laboratories LLC Company Overview 118

5.43.1 Cubed Laboratories LLC Pipeline Products & Ongoing Clinical Trials Overview 118

5.44 Cupid Ltd Company Overview 120

5.44.1 Cupid Ltd Pipeline Products & Ongoing Clinical Trials Overview 120

5.45 Daan Gene Co Ltd Company Overview 121

5.45.1 Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 121

5.46 Defence Science and Technology Laboratory Company Overview 128

5.46.1 Defence Science and Technology Laboratory Pipeline Products & Ongoing Clinical Trials Overview 128

5.47 DIANA Biotechnologies SRO Company Overview 129

5.47.1 DIANA Biotechnologies SRO Pipeline Products & Ongoing Clinical Trials Overview 129

5.48 DiaSorin SpA Company Overview 130

5.48.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 130

5.49 DSX Therapeutics LLC Company Overview 134

5.49.1 DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 134

5.50 Ellume Ltd Company Overview 136

5.50.1 Ellume Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

5.51 Emory University Company Overview 138

5.51.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 138

5.52 Enigma Diagnostics Ltd (Inactive) Company Overview 139

5.52.1 Enigma Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139

5.53 EUROIMMUN US LLC Company Overview 140

5.53.1 EUROIMMUN US LLC Pipeline Products & Ongoing Clinical Trials Overview 140

5.54 First Light Diagnostics Inc Company Overview 141

5.54.1 First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 141

5.55 FK-Biotecnologia SA Company Overview 142

5.55.1 FK-Biotecnologia SA Pipeline Products & Ongoing Clinical Trials Overview 142

5.56 Focus Diagnostics Inc Company Overview 143

5.56.1 Focus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 143

5.57 Foundation for Innovative New Diagnostics Company Overview 144

5.57.1 Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 144

5.58 Fyodor Biotechnologies, Inc. Company Overview 145

5.58.1 Fyodor Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145

5.59 Genekam Biotechnology AG Company Overview 146

5.59.1 Genekam Biotechnology AG Pipeline Products & Ongoing Clinical Trials Overview 146

5.60 Genome Diagnostics Pvt Ltd Company Overview 147

5.60.1 Genome Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 147

5.61 GNA Biosolutions GmbH Company Overview 154

5.61.1 GNA Biosolutions GmbH Pipeline Products & Ongoing Clinical Trials Overview 154

5.62 Godx Inc Company Overview 155

5.62.1 Godx Inc Pipeline Products & Ongoing Clinical Trials Overview 155

5.63 Great Basin Scientific Inc. Company Overview 156

5.63.1 Great Basin Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 156

5.64 Guanine Inc Company Overview 157

5.64.1 Guanine Inc Pipeline Products & Ongoing Clinical Trials Overview 157

5.65 HAV Vaccines Ltd Company Overview 158

5.65.1 HAV Vaccines Ltd Pipeline Products & Ongoing Clinical Trials Overview 158

5.66 HDT Biotech Corp Company Overview 159

5.66.1 HDT Biotech Corp Pipeline Products & Ongoing Clinical Trials Overview 159

5.67 Health and Bliss (Inactive) Company Overview 160

5.67.1 Health and Bliss (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 160

5.68 Helixbind Inc Company Overview 161

5.68.1 Helixbind Inc Pipeline Products & Ongoing Clinical Trials Overview 161

5.69 Helmholtz Centre for Infection Research Company Overview 162

5.69.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 162

5.70 HiberGene Diagnostics Ltd Company Overview 163

5.70.1 HiberGene Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 163

5.71 Hutman Diagnostics AG Company Overview 166

5.71.1 Hutman Diagnostics AG Pipeline Products & Ongoing Clinical Trials Overview 166

5.72 iCubate Inc Company Overview 169

5.72.1 iCubate Inc Pipeline Products & Ongoing Clinical Trials Overview 169

5.73 InBios International Inc Company Overview 170

5.73.1 InBios International Inc Pipeline Products & Ongoing Clinical Trials Overview 170

5.74 Innovative Biosensors, Inc. Company Overview 171

5.74.1 Innovative Biosensors, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171

5.75 InstantLabs Inc Company Overview 172

5.75.1 InstantLabs Inc Pipeline Products & Ongoing Clinical Trials Overview 172

5.76 Institute for Development Research Company Overview 173

5.76.1 Institute for Development Research Pipeline Products & Ongoing Clinical Trials Overview 173

5.77 Jagiellonian University Company Overview 174

5.77.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 174

5.78 Johns Hopkins University Company Overview 175

5.78.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 175

5.79 Kaneka Corp Company Overview 176

5.79.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview 176

5.80 L2 Diagnostics LLC Company Overview 177

5.80.1 L2 Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 177

5.81 Luminex Corp Company Overview 181

5.81.1 Luminex Corp Pipeline Products & Ongoing Clinical Trials Overview 181

5.82 Marx Biotechnology Ltd Company Overview 182

5.82.1 Marx Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

5.83 Master Diagnostica Sociedad Limitada Company Overview 183

5.83.1 Master Diagnostica Sociedad Limitada Pipeline Products & Ongoing Clinical Trials Overview 183

5.84 Medica Corp Company Overview 184

5.84.1 Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 184

5.85 Meridian Bioscience Inc Company Overview 185

5.85.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 185

5.86 MicroPhage Inc (Inactive) Company Overview 188

5.86.1 MicroPhage Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 188

5.87 Molecular Detection Inc (Inactive) Company Overview 193

5.87.1 Molecular Detection Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 193

5.88 MyCartis NV Company Overview 196

5.88.1 MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview 196

5.89 Mylab Discovery Solutions Pvt Ltd Company Overview 197

5.89.1 Mylab Discovery Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 197

5.90 Nanosphere Inc (Inactive) Company Overview 198

5.90.1 Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 198

5.91 National Cheng-Kung University Hospital Company Overview 199

5.91.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 199

5.92 Naval Medical Research Center Company Overview 200

5.92.1 Naval Medical Research Center Pipeline Products & Ongoing Clinical Trials Overview 200

5.93 NeuMoDx Molecular Inc Company Overview 201

5.93.1 NeuMoDx Molecular Inc Pipeline Products & Ongoing Clinical Trials Overview 201

5.94 Newcastle University Company Overview 203

5.94.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 203

5.95 North Carolina State University Company Overview 204

5.95.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 204

5.96 Novartis AG Company Overview 205

5.96.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 205

5.97 OpGen Inc Company Overview 207

5.97.1 OpGen Inc Pipeline Products & Ongoing Clinical Trials Overview 207

5.98 Optolane Technologies Inc Company Overview 208

5.98.1 Optolane Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 208

5.99 Pathogenica Inc Company Overview 209

5.99.1 Pathogenica Inc Pipeline Products & Ongoing Clinical Trials Overview 209

5.100 Pennsylvania State University Company Overview 211

5.100.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 211

5.101 Pictor Ltd Company Overview 212

5.101.1 Pictor Ltd Pipeline Products & Ongoing Clinical Trials Overview 212

5.102 PositiveID Corp Company Overview 213

5.102.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 213

5.103 Presymptom Health Ltd Company Overview 214

5.103.1 Presymptom Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 214

5.104 Proactive Oral Solutions, Inc. Company Overview 217

5.104.1 Proactive Oral Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 217

5.105 ProCelo AS Company Overview 218

5.105.1 ProCelo AS Pipeline Products & Ongoing Clinical Trials Overview 218

5.106 Promyco Diagnostics Ltd (Inactive) Company Overview 225

5.106.1 Promyco Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 225

5.107 Qiagen NV Company Overview 228

5.107.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 228

5.108 Quidel Corp Company Overview 232

5.108.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 232

5.109 RedHill Biopharma Ltd Company Overview 234

5.109.1 RedHill Biopharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 234

5.110 Renishaw Plc Company Overview 235

5.110.1 Renishaw Plc Pipeline Products & Ongoing Clinical Trials Overview 235

5.111 Rheonix Inc Company Overview 237

5.111.1 Rheonix Inc Pipeline Products & Ongoing Clinical Trials Overview 237

5.112 Roche Diagnostics International Ltd Company Overview 238

5.112.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 238

5.113 Rockefeller University Company Overview 243

5.113.1 Rockefeller University Pipeline Products & Ongoing Clinical Trials Overview 243

5.114 Sansure Biotech Inc Company Overview 244

5.114.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 244

5.115 Seegene Inc Company Overview 246

5.115.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 246

5.116 Sex Positive Diagnostics Company Overview 255

5.116.1 Sex Positive Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 255

5.117 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 256

5.117.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 256

5.118 Shenzhen New Industries Biomedical Engineering Co Ltd Company Overview 257

5.118.1 Shenzhen New Industries Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 257

5.119 SomaLogic Inc Company Overview 258

5.119.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 258

5.120 Spanish National Research Council Company Overview 259

5.120.1 Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview 259

5.121 SpeeDx Pty Ltd Company Overview 260

5.121.1 SpeeDx Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 260

5.122 TBG Diagnostics Ltd Company Overview 266

5.122.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 266

5.123 The University of Nottingham Company Overview 267

5.123.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 267

5.124 Tosoh Bioscience Inc Company Overview 268

5.124.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 268

5.125 Transfusion & Transplantation Technologies (Inactive) Company Overview 269

5.125.1 Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 269

5.126 Trillium Diagnostics LLC (Inactive) Company Overview 271

5.126.1 Trillium Diagnostics LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 271

5.127 University at Buffalo Company Overview 272

5.127.1 University at Buffalo Pipeline Products & Ongoing Clinical Trials Overview 272

5.128 University of Calgary Company Overview 273

5.128.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 273

5.129 University of California San Diego Company Overview 274

5.129.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 274

5.130 University of California San Francisco Company Overview 275

5.130.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 275

5.131 University of Cincinnati Company Overview 276

5.131.1 University of Cincinnati Pipeline Products & Ongoing Clinical Trials Overview 276

5.132 University of Leicester Company Overview 277

5.132.1 University of Leicester Pipeline Products & Ongoing Clinical Trials Overview 277

5.133 University of Liverpool Company Overview 278

5.133.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 278

5.134 University of Maryland Baltimore Company Overview 279

5.134.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 279

5.135 University of Melbourne Company Overview 281

5.135.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 281

5.136 University of Michigan Company Overview 282

5.136.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 282

5.137 University of Oxford Company Overview 283

5.137.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 283

5.138 University of Pennsylvania Company Overview 284

5.138.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 284

5.139 University of Strathclyde Company Overview 285

5.139.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 285

5.140 University of Washington Company Overview 286

5.140.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 286

5.141 University of Wisconsin Madison Company Overview 287

5.141.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 287

5.142 Verax Biomedical Inc Company Overview 290

5.142.1 Verax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 290

5.143 Victory Square Health Inc Company Overview 291

5.143.1 Victory Square Health Inc Pipeline Products & Ongoing Clinical Trials Overview 291

5.144 Yale University Company Overview 293

5.144.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 293

6 Bacteriology- Recent Developments 295

6.1 Nov 14, 2022: Accelerate Diagnostics Reports Third Quarter 2022 Financial Results 295

6.2 Nov 03, 2022: Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance 296

6.3 Nov 01, 2022: Genetic Analysis Announces Interim report January – September 2022 300

6.4 Nov 01, 2022: Co-Diagnostics Appoints Dr. Mark Poritz as New Chief Scientific Officer 300

6.5 Nov 01, 2022: Genetic Analysis : Interim report January – September 2022 301

6.6 Oct 27, 2022: OpGen Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2022 and Provides Business Update 302

6.7 Oct 27, 2022: Meridian of Michigan appoints Patricia Graham as CEO 303

6.8 Oct 27, 2022: Co-Diagnostics Announces Third Quarter 2022 Earnings Release Date and Webcast 303

6.9 Oct 27, 2022: Bio-Rad Reports Third-Quarter 2022 Financial Results 304

6.10 Oct 21, 2022: Biocartis Reports Results of Third Quarter of 2022 305

6.11 Oct 19, 2022: Renishaw full-year results reports record revenue increase 306

6.12 Oct 17, 2022: Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022 306

6.13 Oct 13, 2022: Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022 306

6.14 Oct 13, 2022: Novartis to lay off 400 at Dublin campus amid global restructuring 307

6.15 Oct 12, 2022: T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook 307

6.16 Oct 11, 2022: Omega Diagnostics Group Scientific Director to present at FIDHC 308

6.17 Oct 05, 2022: DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument 308

6.18 Sep 30, 2022: Renishaw Annual Report 2022 309

6.19 Sep 27, 2022: Neogen Announces First Quarter Results 311

6.20 Sep 27, 2022: Omega Diagnostics Group PLC Posting of Annual Report and confirmation of AGM 313

6.21 Sep 16, 2022: Renishaw Preliminary announcement of results for the year ended 30 June 2022 313

6.22 Sep 12, 2022: Co-Diagnostics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 314

6.23 Sep 12, 2022: Neogen Announces the Appointment of Two New Board Members 314

6.24 Sep 08, 2022: Cardinal Health Announces Pharmaceutical Segment Organizational Changes 315

6.25 Sep 08, 2022: Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference 315

6.26 Sep 06, 2022: Labcorp to Speak at the Baird 2022 Global Healthcare Conference 316

6.27 Sep 05, 2022: Renishaw Register for the 2022 full-year results webcast 316

6.28 Sep 01, 2022: Bayer Announces Appointment of Kimberly Mathisen to Supervisory Board 316

6.29 Sep 01, 2022: Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis 316

6.30 Aug 30, 2022: Biomerica Plans Launch of InFoods IBS Test; Names Robert Carlson as Chief Commercial Officer 317

6.31 Aug 25, 2022: Biocartis Announces 2022 Half-Year Results on 1 September 2022 318

6.32 Aug 24, 2022: BD to Present at the Wells Fargo 2022 Healthcare Conference 318

6.33 Aug 24, 2022: New line of electrochemistry bench meters simplify pH, conductivity and dissolved oxygen measurement 318

6.34 Aug 23, 2022: Novartis set to eliminate many leadership positions as part of 1,400 layoffs in Switzerland 319

6.35 Aug 22, 2022: Co-Diagnostics to Present at 14th Next Generation Dx Summit in Washington, D.C. 319

6.36 Aug 18, 2022: QIAGEN issues 2021 Sustainability Report 319

6.37 Aug 15, 2022: MyMD Pharmaceuticals announce quarter ended June 30, 2022 320

6.38 Aug 11, 2022: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022 322

6.39 Aug 11, 2022: Co-Diagnostics Reports Second Quarter 2022 Financial Results 323

6.40 Aug 10, 2022: Biohit announce Half Year Financial Report

2022. 324

6.41 Aug 01, 2022: Cardinal Health Names Michelle Greene as Chief Information Officer 331

6.42 Jul 28, 2022: Labcorp Announces 2022 Second Quarter Results 331

6.43 Jul 28, 2022: Bio-rad Reports Second-quarter 2022 Financial Results 335

6.44 Jul 26, 2022: QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook 339

6.45 Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments 340

6.46 Jul 24, 2022: Central Trust Buys 136 Shares of Novartis AG 341

6.47 Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance 341

6.48 Jul 18, 2022: Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022 341

6.49 Jul 14, 2022: MedMira Strengthens and Expands Board 342

6.50 Jul 08, 2022: Opgen Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2022 342

6.51 Jul 07, 2022: Neogen Announces Pricing of $350.0 Million Senior Notes Offering and Entry into $800.0 Million Senior Secured Credit Agreement by Garden SpinCo 343

6.52 Jul 07, 2022: Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2022 on August 11 344

6.53 Jul 05, 2022: Hologic to Announce Financial Results for the Third Quarter of Fiscal 2022 on Wednesday, July 27, 2022 344

6.54 Jul 01, 2022: Novartis Leaning Toward Spinoff of $25 Billion Generics Arm 344

6.55 Jun 28, 2022: Novartis to cut up to 8,000 jobs globally 344

6.56 Jun 24, 2022: Quotient Ltd Provides Fourth Quarter Fiscal 2022 Results and Business Update 344

6.57 Jun 24, 2022: Quotient Provides Fourth Quarter Fiscal 2022 Results and Business Update 347

6.58 Jun 21, 2022: Quotient Reschedules Fourth Quarter and Full Year 2022 Financial Results Announcement to Friday, June 24th and Provides a Preview of Financials 347

6.59 Jun 17, 2022: Quotient to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on June 22nd 348

6.60 Jun 15, 2022: Co-Diagnostics to Present at Sidoti Summer Small Cap Virtual Conference 348

6.61 Jun 09, 2022: EKF Diagnostics Holdings : Launch of EKF Link 348

6.62 Jun 08, 2022: PixCell Medical Names Mark Erez as Chief Financial Officer 349

6.63 Jun 07, 2022: BD Names Simon Campion as Medical Segment President 350

6.64 Jun 07, 2022: Daan Gene Announcement on the Resignation of the General Manager of the Company 350

6.65 Jun 02, 2022: BD to Present at Goldman Sachs 43rd Annual Global Healthcare Conference 350

6.66 Jun 02, 2022: Eisai to Present Latest Data on Lemborexant at the 36th Annual Sleep 2022 Meeting 350

6.67 May 26, 2022: Quest Diagnostics to Speak at the Jefferies Healthcare Conference 351

6.68 May 24, 2022: Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS) 351

6.69 May 23, 2022: Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022 352

6.70 May 19, 2022: Co-Diagnostics to Participate in the H.C. Wainwright 2022 Global Investment Conference on May 23-26 352

6.71 May 19, 2022: U of I trustees appoint new chancellor at UIS 352

6.72 May 18, 2022: Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer for North America 354

6.73 May 17, 2022: Labcorp to Speak at the UBS 2022 Global Healthcare Conference 354

6.74 May 16, 2022: Accelerate Diagnostics Reports First Quarter 2022 Financial Results 354

6.75 May 13, 2022: Seegene reports first quarter 2022 financial results 355

6.76 May 11, 2022: Quest Diagnostics to Speak at the UBS 2022 Global Healthcare Conference 356

6.77 May 10, 2022: Bayer Group Announced First quarter 2022 strong sales and earnings growth 356

6.78 May 10, 2022: Eppendorf increases 2021 revenue to €1.1 billion 358

6.79 May 05, 2022: Cardinal Health Reports Third Quarter Fiscal 2022 Results 359

6.80 May 04, 2022: Luminex announces upcoming initial public offering 361

6.81 May 04, 2022: Labcorp to Webcast Its Annual Meeting of Shareholders 361

6.82 May 04, 2022: Ortho Clinical Diagnostics Reports First Quarter 2022 Results 361

6.83 Apr 29, 2022: BD to Present at the BofA Securities 2022 Healthcare Conference 362

6.84 Apr 28, 2022: T2 Biosystems Announces Formation and Members of Scientific Advisory Board 362

6.85 Apr 28, 2022: Co-Diagnostics Announces First Quarter 2022 Earnings Release Date and Webcast 365

6.86 Apr 26, 2022: Quotient Announces Appointment of New Board Member 365

6.87 Apr 25, 2022: PixCell Medical Appoints Ryan Venturi as General Manager of Newly Opened US Office 365

6.88 Apr 25, 2022: EKF Diagnostics Holdings announces Posting of Annual Report & Accounts &Notice of AGM 366

6.89 Apr 21, 2022: Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35% 366

6.90 Apr 21, 2022: Bayer appoints Tara Frenkl as the new Head of Oncology Development at its Oncology Strategic Business Unit 367

6.91 Apr 20, 2022: Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022 368

6.92 Apr 14, 2022: Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021 368

6.93 Apr 14, 2022: nRichDX and Eppendorf to jointly present at ESHG 2022 Meeting 369

6.94 Apr 12, 2022: Queen’s University to host Belfast/Good Friday Agreement 25th Anniversary Conference 369

6.95 Apr 11, 2022: Thermo Fisher Scientific to Host Investor Day 370

6.96 Apr 07, 2022: Quidel Announces Preliminary Revenue for First Quarter 2022 370

6.97 Apr 06, 2022: OpGen’s subsidiary Ares Genetics provides update on collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR) 370

6.98 Apr 04, 2022: Novartis appoints Shreeram Aradhye as chief medical officer 371

6.99 Mar 31, 2022: Renishaw announces Directorate Change 371

6.100 Mar 29, 2022: Accelerate Diagnostics launches Arc system for use in blood culture test 372

6.101 Mar 29, 2022: T2 Biosystems to Host Analyst and Investor Day on April 12, 2022 372

6.102 Mar 29, 2022: Genedrive Announces Interim results to 31 December 2021 373

6.103 Mar 24, 2022: Neogen Announces Third Quarter Results 373

6.104 Mar 17, 2022: Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary 375

6.105 Mar 17, 2022: Co-Diagnostics Makes Strategic Additions to Scientific Advisory Board 376

6.106 Mar 17, 2022: Genedrive Appoints Russell John Shaw as Chief Financial Officer 376

6.107 Mar 15, 2022: OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 378

6.108 Mar 14, 2022: Co-diagnostics Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Webcast 378

6.109 Mar 14, 2022: Qiagen Announces 20-f Annual Report Filing for 2021 Results 378

6.110 Mar 08, 2022: Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2021 Financial Results 378

6.111 Mar 04, 2022: Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting 379

6.112 Mar 03, 2022: binx health Announces Appointment of UnitedHealth Group’s Optum Rx Chief Financial Officer Jeff Grosklags to its Board of Directors 380

6.113 Mar 02, 2022: Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business 381

6.114 Mar 01, 2022: Cardiff Oncology to Participate in Cowen’s 42nd Annual Healthcare Conference 381

6.115 Feb 24, 2022: Accelerate Diagnostics scheduled call to review 2021 fourth quarter and full year results 382

6.116 Feb 24, 2022: BD to Present at the Cowen 42nd Annual Health Care Conference 382

6.117 Feb 23, 2022: embecta to Host Virtual Investor Event Ahead of Planned Spinoff from BD 382

6.118 Feb 23, 2022: Bd Appoints Shana Neal as Chief People Officer 382

6.119 Feb 17, 2022: Biocartis Group announces 2021 full year results on 24 february 2022 383

6.120 Feb 17, 2022: Seegene Announces Q4 and Full-Year 2021 Financial Results 383

6.121 Feb 16, 2022: Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results 384

6.122 Feb 15, 2022: T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement 386

6.123 Feb 14, 2022: Bio-Rad Laboratories to Post Q1 2022 Earnings of $2.80 Per Share, Jefferies Financial Group Forecasts 386

6.12

Table

Bacteriology – Pipeline Products by Stage of Development 27

Bacteriology – Pipeline Products by Segment 28

Bacteriology – Pipeline Products by Territory 29

Bacteriology – Pipeline Products by Regulatory Path 30

Bacteriology – Pipeline Products by Estimated Approval Date 31

Bacteriology – Ongoing Clinical Trials 32

Bacteriology Companies – Pipeline Products by Stage of Development 33

Bacteriology – Pipeline Products by Stage of Development 39

3a-Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 46

Peptide-Based Biosensor Screening Test – Scarlet Fever – Product Status 46

Peptide-Based Biosensor Screening Test – Scarlet Fever – Product Description 46

Abacus Diagnostica Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

GenomEra Acinetobacter Baumannii Assay – Product Status 47

GenomEra Acinetobacter Baumannii Assay – Product Description 47

Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 48

MOLgen DNA Borrelia miyamotoi Set 2 Kit – Product Status 49

MOLgen DNA Borrelia miyamotoi Set 2 Kit – Product Description 49

MOLgen DNA Chlamydia Trachomatis / Ureaplasma Urealyticum Set 2 Kit – Product Status 49

MOLgen DNA Chlamydia Trachomatis / Ureaplasma Urealyticum Set 2 Kit – Product Description 50

MOLgen DNA Chlamydophila pneumoniae Set 2 Kit – Product Status 50

MOLgen DNA Chlamydophila pneumoniae Set 2 Kit – Product Description 50

MOLgen DNA Gardnerella Vaginalis / Atopobium Vaginae Set 2 Kit – Product Status 51

MOLgen DNA Gardnerella Vaginalis / Atopobium Vaginae Set 2 Kit – Product Description 51

MOLgen DNA Gardnerella Vaginalis Set 2 Kit – Product Status 51

MOLgen DNA Gardnerella Vaginalis Set 2 Kit – Product Description 52

MOLgen DNA Haemophilus Influenza Set 2 Kit – Product Status 52

MOLgen DNA Haemophilus Influenza Set 2 Kit – Product Description 52

MOLgen DNA Mobiluncus mulieris / Mobiluncus curtisi Set 2 Kit – Product Status 53

MOLgen DNA Mobiluncus mulieris / Mobiluncus curtisi Set 2 Kit – Product Description 53

MOLgen DNA Mycoplasma Genitalium Set 2 Kit – Product Status 53

MOLgen DNA Mycoplasma Genitalium Set 2 Kit – Product Description 54

MOLgen DNA Mycoplasma Hominis Set 2 Kit – Product Status 54

MOLgen DNA Mycoplasma Hominis Set 2 Kit – Product Description 54

MOLgen DNA Mycoplasma pneumoniae Set 2 Kit – Product Status 55

MOLgen DNA Mycoplasma pneumoniae Set 2 Kit – Product Description 55

MOLgen DNA Prevotella Species / Leptotrichia Amnionii Group Set 2 Kit – Product Status 55

MOLgen DNA Prevotella Species / Leptotrichia Amnionii Group Set 2 Kit – Product Description 56

MOLgen DNA Streptococcus pneumoniae Set 2 Kit – Product Status 56

MOLgen DNA Streptococcus pneumoniae Set 2 Kit – Product Description 56

MOLgen DNA Ureaplasma Species Set 2 Kit – Product Status 57

MOLgen DNA Ureaplasma Species Set 2 Kit – Product Description 57

MOLgen DNA Ureaplasma Urealyticum / Ureaplasma Parvum Set 2 Kit – Product Status 57

MOLgen DNA Ureaplasma Urealyticum / Ureaplasma Parvum Set 2 Kit – Product Description 58

MOLgen DNA Ureaplasma Urealyticum Set 2 Kit – Product Status 58

MOLgen DNA Ureaplasma Urealyticum Set 2 Kit – Product Description 58

MOLgen Lactonorm Set 2 Kit – Product Status 59

MOLgen Lactonorm Set 2 Kit – Product Description 59

MOLgen Legionella pneumophila Set 2 Kit – Product Status 59

MOLgen Legionella pneumophila Set 2 Kit – Product Description 60

Advanced Laboratory Services, INC. Pipeline Products & Ongoing Clinical Trials Overview 61

Borrelia Diagnostic Test – Product Status 61

Borrelia Diagnostic Test – Product Description 61

Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 62

Lab-On-A-Film Multiplexed Test – Product Status 62

Lab-On-A-Film Multiplexed Test – Product Description 63

Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 64

AIMS System – Borrelia VisE-1/pepC10 Test – Product Status 64

AIMS System – Borrelia VisE-1/pepC10 Test – Product Description 64

AIMS System – Syphilis Test – Product Status 65

AIMS System – Syphilis Test – Product Description 65

AtheNA Multi-Lyte System – Syphilis Test – Product Status 65

AtheNA Multi-Lyte System – Syphilis Test – Product Description 65

American Bio Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 66

Syphilis Test Strip – Product Status 66

Syphilis Test Strip – Product Description 66

Amity University Pipeline Products & Ongoing Clinical Trials Overview 67

Diagnostic Kit – Leptospirosis – Product Status 67

Diagnostic Kit – Leptospirosis – Product Description 67

Immunosensor – Cholera – Product Status 68

Immunosensor – Cholera – Product Description 68

Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Multiplex Pathogen Detection Test – Product Status 69

Multiplex Pathogen Detection Test – Product Description 69

Antigen Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Pan-Proteome Microarray Test – Syphilis – Product Status 70

Pan-Proteome Microarray Test – Syphilis – Product Description 70

Applied BioCode Inc Pipeline Products & Ongoing Clinical Trials Overview 71

BioCode Vaginosis/Vaginitis Panel – Product Status 71

BioCode Vaginosis/Vaginitis Panel – Product Description 71

Ares Genetics GmbH Pipeline Products & Ongoing Clinical Trials Overview 72

ARESupa – Product Status 72

ARESupa – Product Description 72

Aseptika Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

Home-Use Sputum Test – Bacterial Lung Infection – Product Status 73

Home-Use Sputum Test – Bacterial Lung Infection – Product Description 73

Astute Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 74

Diagnostic Test – Sepsis – Product Status 74

Diagnostic Test – Sepsis – Product Description 74

Asylia Diagnostics BV Pipeline Products & Ongoing Clinical Trials Overview 75

CDx Assay – Sepsis – Product Status 75

CDx Assay – Sepsis – Product Description 75

Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76

Ayanda SLIC Pneumonia – Product Status 76

Ayanda SLIC Pneumonia – Product Description 76

Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 77

DxN VERIS CT/NG Assay – Product Status 77

DxN VERIS CT/NG Assay – Product Description 77

DxN VERIS MRSA Assay – Product Status 78

DxN VERIS MRSA Assay – Product Description 78

Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview 79

SeptiCyte Triage – Product Status 79

SeptiCyte Triage – Product Description 79

Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview 80

Metabolomic Biomarker Assay – Sepsis – Product Status 80

Metabolomic Biomarker Assay – Sepsis – Product Description 80

BioFilm Control SAS Pipeline Products & Ongoing Clinical Trials Overview 81

Antibiofilmogram Kit – Product Status 81

Antibiofilmogram Kit – Product Description 81

BioHelix Corp Pipeline Products & Ongoing Clinical Trials Overview 82

IsoAmp Assay – Chlamydia Trachomatis/Neisseria Gonorrhoeae – Product Status 82

IsoAmp Assay – Chlamydia Trachomatis/Neisseria Gonorrhoeae – Product Description 82

Biointerfaces Institute Pipeline Products & Ongoing Clinical Trials Overview 83

Diagnostic Test – E.Coli – Product Status 83

Diagnostic Test – E.Coli – Product Description 83

Biois Corp Pipeline Products & Ongoing Clinical Trials Overview 84

Nanogold – Coliform Bacteria Detection Kit – Product Status 84

Nanogold – Coliform Bacteria Detection Kit – Product Description 84

Nanogold – Urinary Tract Infection Kit – Product Status 85

Nanogold – Urinary Tract Infection Kit – Product Description 85

BioMaxima SA Pipeline Products & Ongoing Clinical Trials Overview 86

Diagnostic Test – Bacterial Infection – Product Status 86

Diagnostic Test – Bacterial Infection – Product Description 86

bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 87

NucliSENS EasyQ Legionella spp Molecular Test – Product Status 87

NucliSENS EasyQ Legionella spp Molecular Test – Product Description 87

NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test – Product Status 88

NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test – Product Description 88

Biopeptide corp Pipeline Products & Ongoing Clinical Trials Overview 89

Multiplex Serologic Assay – Lyme disease – Product Status 89

Multiplex Serologic Assay – Lyme disease – Product Description 89

BioSentinel Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90

BoNT Detection Assay – Product Status 90

BoNT Detection Assay – Product Description 90

Biotechnology Assets SA Pipeline Products & Ongoing Clinical Trials Overview 91

BNTIVD003 Assay – Sepsis – Product Status 91

BNTIVD003 Assay – Sepsis – Product Description 91

Bordeaux University Hospital Pipeline Products & Ongoing Clinical Trials Overview 92

Predictive Test – Anti-TNF Therapy Monitoring – Product Status 92

Predictive Test – Anti-TNF Therapy Monitoring – Product Description 92

Brigham Young University Inc Pipeline Products & Ongoing Clinical Trials Overview 93

Multiplexed Nucleic Acid Based Assay – Product Status 93

Multiplexed Nucleic Acid Based Assay – Product Description 93

C3J Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 94

Companion Diagnostic Assay – C16G2 – Product Status 94

Companion Diagnostic Assay – C16G2 – Product Description 94

Diagnostic Test – Streptococcus Mutans – Product Status 95

Diagnostic Test – Streptococcus Mutans – Product Description 95

Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview 96

Aware – Syphilis Assay – Product Status 96

Aware – Syphilis Assay – Product Description 96

Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 97

BioLis 24i Analyzer – RPR Syphilis Assay – Product Status 97

BioLis 24i Analyzer – RPR Syphilis Assay – Product Description 97

CLC 720 Analyzer – Syphilis Assay – Product Status 98

CLC 720 Analyzer – Syphilis Assay – Product Description 98

CellCarta Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 99

Diagnostic Assay – Brucellosis – Product Status 99

Diagnostic Assay – Brucellosis – Product Description 99

Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview 100

Antibody Based Diagnostic Kit – Pseudomonas Infection – Product Status 100

Antibody Based Diagnostic Kit – Pseudomonas Infection – Product Description 100

Diagnostic Kit – Stahphylococcus Aureus – Product Status 101

Diagnostic Kit – Stahphylococcus Aureus – Product Description 101

Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 102

Xpert Carba-R NxG Test – Product Status 102

Xpert Carba-R NxG Test – Product Description 103

Xpert CT/NG FluroQ Resistant Trichomonas Assay – Product Status 103

Xpert CT/NG FluroQ Resistant Trichomonas Assay – Product Description 103

Xpert CT/NG LBC Assay – Product Status 104

Xpert CT/NG LBC Assay – Product Description 104

Xpert GBS Ultra – Product Status 104

Xpert GBS Ultra – Product Description 105

Xpert Group A Strep Assay – Product Status 105

Xpert Group A Strep Assay – Product Description 105

Xpert Group A/C Strep Assay – Product Status 106

Xpert Group A/C Strep Assay – Product Description 106

Xpert Meningitis/Encephalitis Assay – Product Status 106

Xpert Meningitis/Encephalitis Assay – Product Description 107

Xpert Next Generation MRSA/SA SSTI Assay – Product Status 107

Xpert Next Generation MRSA/SA SSTI Assay – Product Description 107

Xpert Next Generation SA Nasal Complete Assay – Product Status 108

Xpert Next Generation SA Nasal Complete Assay – Product Description 108

Xpert Pertussis Assay – Product Status 108

Xpert Pertussis Assay – Product Description 109

Xpert Vaginitis Assay – Product Status 109

Xpert Vaginitis Assay – Product Description 109

Xpert VAP Gram Negative Assay – Product Status 110

Xpert VAP Gram Negative Assay – Product Description 110

Xpress Strep A Assay – Product Status 110

Xpress Strep A Assay – Product Description 111

Children’s Hospital of Michigan Pipeline Products & Ongoing Clinical Trials Overview 112

Noninvasive Diagnostic Test – Bacterial Infections – Product Status 112

Noninvasive Diagnostic Test – Bacterial Infections – Product Description 112

China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 113

SPR Based DNA Chip – Bacterial Infection – Product Status 113

SPR Based DNA Chip – Bacterial Infection – Product Description 113

Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 114

Co-Dx Test – Gonorrhoea/Chlamydia – Product Status 114

Co-Dx Test – Gonorrhoea/Chlamydia – Product Description 114

Conrad Pipeline Products & Ongoing Clinical Trials Overview 115

Diagnostic Assay – Bacterial Vaginosis – Product Status 115

Diagnostic Assay – Bacterial Vaginosis – Product Description 115

Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 116

Brainµ Diagnostic Test – Product Status 116

Brainµ Diagnostic Test – Product Description 116

Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 117

Sepsis Diagnostic Panel – Product Status 117

Sepsis Diagnostic Panel – Product Description 117

Cubed Laboratories LLC Pipeline Products & Ongoing Clinical Trials Overview 118

NESDEP IU – Bacterial Meningitis – Product Status 118

NESDEP IU – Bacterial Meningitis – Product Description 118

NESDEP IU – Pseudomonas – Product Status 119

NESDEP IU – Pseudomonas – Product Description 119

Cupid Ltd Pipeline Products & Ongoing Clinical Trials Overview 120

Syphilis RDT Test Kit – Product Status 120

Syphilis RDT Test Kit – Product Description 120

Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 121

Real Time PCR Kit – BA – Product Status 121

Real Time PCR Kit – BA – Product Description 122

Real Time PCR Kit – Enterobacter Sakazakii – Product Status 122

Real Time PCR Kit – Enterobacter Sakazakii – Product Description 122

Real Time PCR Kit – Salmonella – Product Status 123

Real Time PCR Kit – Salmonella – Product Description 123

Real Time PCR Kit – Shigella – Product Status 123

Real Time PCR Kit – Shigella – Product Description 124

Real Time PCR Kit – Streptococcus A – Product Status 124

Real Time PCR Kit – Streptococcus A – Product Description 124

Real Time PCR Kit – Typhoid Bacillus – Product Status 125

Real Time PCR Kit – Typhoid Bacillus – Product Description 125

Real Time PCR Kit – Vibrio Cholerae General – Product Status 125

Real Time PCR Kit – Vibrio Cholerae General – Product Description 126

Real Time PCR Kit – Vibrio Parahaemolyticus – Product Status 126

Real Time PCR Kit – Vibrio Parahaemolyticus – Product Description 126

Real Time PCR Kit – Yersinia Pestis – Product Status 127

Real Time PCR Kit – Yersinia Pestis – Product Description 127

Defence Science and Technology Laboratory Pipeline Products & Ongoing Clinical Trials Overview 128

Diagnostic Test – Sepsis – Product Status 128

Diagnostic Test – Sepsis – Product Description 128

DIANA Biotechnologies SRO Pipeline Products & Ongoing Clinical Trials Overview 129

Gingipains – Porphyromonas Gingivalis Assay – Product Status 129

Gingipains – Porphyromonas Gingivalis Assay – Product Description 129

DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 130

Diagnostic Assay – Atypical Pneumonia – Product Status 130

Diagnostic Assay – Atypical Pneumonia – Product Description 131

Diagnostic Assay – Group B Streptococcus Infection – Product Status 131

Diagnostic Assay – Group B Streptococcus Infection – Product Description 131

Diagnostic Assay – Mycoplasma Genitalium Infection – Product Status 132

Diagnostic Assay – Mycoplasma Genitalium Infection – Product Description 132

Diagnostic Assay – Streptococcus Pneumonia – Product Status 132

Diagnostic Assay – Streptococcus Pneumonia – Product Description 132

Diagnostic Assay – Vaginosis – Product Status 133

Diagnostic Assay – Vaginosis – Product Description 133

Neisseria Meningitidis Assay – Product Status 133

Neisseria Meningitidis Assay – Product Description 133

DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 134

Clinical Laboratory Auto-analyzer Test – Sepsis – Product Status 134

Clinical Laboratory Auto-analyzer Test – Sepsis – Product Description 134

Flow Cytometry Clinical Test – Sepsis – Product Status 135

Flow Cytometry Clinical Test – Sepsis – Product Description 135

Ellume Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

ESP-Based Diagnostic Test – Gonorrhoea – Product Status 136

ESP-Based Diagnostic Test – Gonorrhoea – Product Description 136

ESP-Based Diagnostic Test – Group A Streptococci – Product Status 137

ESP-Based Diagnostic Test – Group A Streptococci – Product Description 137

Emory University Pipeline Products & Ongoing Clinical Trials Overview 138

Diagnostic Test – Antibiotic Resistance – Product Status 138

Diagnostic Test – Antibiotic Resistance – Product Description 138

Enigma Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139

Enigma ML – MRSA – Product Status 139

Enigma ML – MRSA – Product Description 139

EUROIMMUN US LLC Pipeline Products & Ongoing Clinical Trials Overview 140

Diagnostic Kit – Yersinia Enterocolitica – Product Status 140

Diagnostic Kit – Yersinia Enterocolitica – Product Description 140

First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 141

MultiPath Carbapenem-Resistant Enterobacteriaceae Test – Product Status 141

MultiPath Carbapenem-Resistant Enterobacteriaceae Test – Product Description 141

FK-Biotecnologia SA Pipeline Products & Ongoing Clinical Trials Overview 142

Diagnostic Test – Treponematoses – Product Status 142

Diagnostic Test – Treponematoses – Product Description 142

Focus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 143

Simplexa MRSA Direct – Product Status 143

Simplexa MRSA Direct – Product Description 143

Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 144

Lamp Assay – Buruli Ulcer – Product Status 144

Lamp Assay – Buruli Ulcer – Product Description 144

Fyodor Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145

Urine Based Test – Leptospira Infection – Product Status 145

Urine Based Test – Leptospira Infection – Product Description 145

Genekam Biotechnology AG Pipeline Products & Ongoing Clinical Trials Overview 146

Listeria Monocytogenes Serotyping PCR Kit – Product Status 146

Listeria Monocytogenes Serotyping PCR Kit – Product Description 146

Genome Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 147

Campylobacter Real Time PCR Kit – Product Status 147

Campylobacter Real Time PCR Kit – Product Description 147

ECOLI 0157 Real Time PCR Kit – Product Status 148

ECOLI 0157 Real Time PCR Kit – Product Description 148

INH resistance Real Time PCR Kit – Product Status 148

INH resistance Real Time PCR Kit – Product Description 149

Listeria Real Time PCR Kit – Product Status 149

Listeria Real Time PCR Kit – Product Description 149

Neisseria Gonorrhoeae Real Time PCR Kit – Product Status 150

Neisseria Gonorrhoeae Real Time PCR Kit – Product Description 150

Pan Bacterial Real Time PCR Kit – Product Status 150

Pan Bacterial Real Time PCR Kit – Product Description 151

Rifampicin Resistance Real Time PCR Kit – Product Status 151

Rifampicin Resistance Real Time PCR Kit – Product Description 151

Salmonella Real Time PCR Kit – Product Status 152

Salmonella Real Time PCR Kit – Product Description 152

Shiga Toxins Real Time PCR Kit – Product Status 152

Shiga Toxins Real Time PCR Kit – Product Description 153

Streptococcus Mutans Real Time PCR Kit – Product Status 153

Streptococcus Mutans Real Time PCR Kit – Product Description 153

GNA Biosolutions GmbH Pipeline Products & Ongoing Clinical Trials Overview 154

KAREL – Product Status 154

KAREL – Product Description 154

Godx Inc Pipeline Products & Ongoing Clinical Trials Overview 155

Diagnostic Test – Bacterial Infections – Product Status 155

Diagnostic Test – Bacterial Infections – Product Description 155

Great Basin Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 156

Diagnostic Assay – Chlamydia/Gonnorhea – Product Status 156

Diagnostic Assay – Chlamydia/Gonnorhea – Product Description 156

Guanine Inc Pipeline Products & Ongoing Clinical Trials Overview 157

Guanine Amplified Assay Kit – Bacteria – Product Status 157

Guanine Amplified Assay Kit – Bacteria – Product Description 157

HAV Vaccines Ltd Pipeline Products & Ongoing Clinical Trials Overview 158

MAP Diagnostic Test – Product Status 158

MAP Diagnostic Test – Product Description 158

HDT Biotech Corp Pipeline Products & Ongoing Clinical Trials Overview 159

Diagnostic Test – Leprosy – Product Status 159

Diagnostic Test – Leprosy – Product Description 159

Health and Bliss (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 160

Screening Assay – Strep – Product Status 160

Screening Assay – Strep – Product Description 160

Helixbind Inc Pipeline Products & Ongoing Clinical Trials Overview 161

dsDNA Invasion Array – Product Status 161

dsDNA Invasion Array – Product Description 161

Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 162

PCR Based Diagnostic Assay – Streptococcus Anginosus/Constellatus – Product Status 162

PCR Based Diagnostic Assay – Streptococcus Anginosus/Constellatus – Product Description 162

HiberGene Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 163

Diagnostic Assay – Group A Streptococcus – Product Status 163

Diagnostic Assay – Group A Streptococcus – Product Description 163

Diagnostic Assay – MRSA – Product Status 164

Diagnostic Assay – MRSA – Product Description 164

Diagnostic Test – Pneumococcal Meningitis – Product Status 164

Diagnostic Test – Pneumococcal Meningitis – Product Description 165

Hutman Diagnostics AG Pipeline Products & Ongoing Clinical Trials Overview 166

Fever-Gene – Product Status 166

Fever-Gene – Product Description 166

Meningo-Gene – Version 1 – Product Status 167

Meningo-Gene – Version 1 – Product Description 167

Pneumo-Gene – Product Status 167

Pneumo-Gene – Product Description 168

iCubate Inc Pipeline Products & Ongoing Clinical Trials Overview 169

iC-Myco Assay – Product Status 169

iC-Myco Assay – Product Description 169

InBios International Inc Pipeline Products & Ongoing Clinical Trials Overview 170

Leprosy Detect ELISA Kit – Product Status 170

Leprosy Detect ELISA Kit – Product Description 170

Innovative Biosensors, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171

Diagnostic Test – MRSA – Product Status 171

Diagnostic Test – MRSA – Product Description 171

InstantLabs Inc Pipeline Products & Ongoing Clinical Trials Overview 172

RT – PCR MRSA Assay – Product Status 172

RT – PCR MRSA Assay – Product Description 172

Institute for Development Research Pipeline Products & Ongoing Clinical Trials Overview 173

Diagnostic Assay – Neonatal Bacterial Infections – Product Status 173

Diagnostic Assay – Neonatal Bacterial Infections – Product Description 173

Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 174

Diagnostic Assay – Streptococcus Infection – Product Status 174

Diagnostic Assay – Streptococcus Infection – Product Description 174

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 175

Biomarker – Infectious Disease – Product Status 175

Biomarker – Infectious Disease – Product Description 175

Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview 176

DNA Detection Kit – Acid-Fast Bacillus – Product Status 176

DNA Detection Kit – Acid-Fast Bacillus – Product Description 176

L2 Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 177

Diagnostic Assay – Human Leptospirosis – Product Status 177

Diagnostic Assay – Human Leptospirosis – Product Description 177

Diagnostic Test – Borrelia Miyamotoi – Product Status 178

Diagnostic Test – Borrelia Miyamotoi – Product Description 178

ELISA-Based BFT Assay – Product Status 178

ELISA-Based BFT Assay – Product Description 179

ELISA-Based Immunoglobulins BFT Assay – Product Status 179

ELISA-Based Immunoglobulins BFT Assay – Product Description 179

PCR-Based ETBF Assay – Product Status 180

PCR-Based ETBF Assay – Product Description 180

Luminex Corp Pipeline Products & Ongoing Clinical Trials Overview 181

Diagnostic Assay – MRSA – Product Status 181

Diagnostic Assay – MRSA – Product Description 181

Marx Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

Blood Test – Bacterial Infections – Product Status 182

Blood Test – Bacterial Infections – Product Description 182

Master Diagnostica Sociedad Limitada Pipeline Products & Ongoing Clinical Trials Overview 183

MDR-TB DNA Flow Chip Test – Product Status 183

MDR-TB DNA Flow Chip Test – Product Description 183

Medica Corp Pipeline Products & Ongoing Clinical Trials Overview 184

EasyRA Analyzer – ASO Assay – Product Status 184

EasyRA Analyzer – ASO Assay – Product Description 184

Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 185

Illumigene E. coli Assay – Product Status 185

Illumigene E. coli Assay – Product Description 185

Immunoassay – C. Difficile – Product Status 186

Immunoassay – C. Difficile – Product Description 186

Immunoassay – Streptococcus pneumoniae / Legionella Infection – Product Status 186

Immunoassay – Streptococcus pneumoniae / Legionella Infection – Product Description 187

MicroPhage Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 188

Diagnostic Test – Respiratory Infection – Product Status 188

Diagnostic Test – Respiratory Infection – Product Description 189

Diagnostic Test – Urinary Tract Infection – Product Status 189

Diagnostic Test – Urinary Tract Infection – Product Description 189

KeyPath Clindamycin Test – Product Status 190

KeyPath Clindamycin Test – Product Description 190

KeyPath MRSA/MSSA Skin And Soft Tissue Infection Test – Product Status 190

KeyPath MRSA/MSSA Skin And Soft Tissue Infection Test – Product Description 191

MicroPhage Vancomycin Tolerance Test – Product Status 191

MicroPhage Vancomycin Tolerance Test – Product Description 191

MRSA/MSSA Screening Test – Product Status 192

MRSA/MSSA Screening Test – Product Description 192

Molecular Detection Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 193

Diagnostic Assay – Bloodstream MRSA – Product Status 193

Diagnostic Assay – Bloodstream MRSA – Product Description 193

Diagnostic Assay – BloodStream VR Infection – Product Status 194

Diagnostic Assay – BloodStream VR Infection – Product Description 194

Molecular Diagnostic Panel – Sepsis – Product Status 194

Molecular Diagnostic Panel – Sepsis – Product Description 195

MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview 196

Diagnostic Test – Sepsis – Product Status 196

Diagnostic Test – Sepsis – Product Description 196

Mylab Discovery Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 197

Compact x System – Septicemia Screening Test – Product Status 197

Compact x System – Septicemia Screening Test – Product Description 197

Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 198

Ultra-Sensitive Protein Assay – Sepsis – Product Status 198

Ultra-Sensitive Protein Assay – Sepsis – Product Description 198

National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 199

Microfluidic Chip – Product Status 199

Microfluidic Chip – Product Description 199

Naval Medical Research Center Pipeline Products & Ongoing Clinical Trials Overview 200

Anaplasma Phagocytophilum Amplification Assay – Product Status 200

Anaplasma Phagocytophilum Amplification Assay – Product Description 200

NeuMoDx Molecular Inc Pipeline Products & Ongoing Clinical Trials Overview 201

NeuMoDx Assay – MG Resistance – Product Status 201

NeuMoDx Assay – MG Resistance – Product Description 201

NeuMoDx GAS Assay – Product Status 202

NeuMoDx GAS Assay – Product Description 202

Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 203

Hand-Held Sensor – Product Status 203

Hand-Held Sensor – Product Description 203

North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 204

Diagnostic Assay – Campylobacter Jejuni – Product Status 204

Diagnostic Assay – Campylobacter Jejuni – Product Description 204

Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 205

Diagnostic Test – Group B Streptococcus – Product Status 205

Diagnostic Test – Group B Streptococcus – Product Description 205

Diagnostic Test – Staphylococcus aureus – Product Status 206

Diagnostic Test – Staphylococcus aureus – Product Description 206

OpGen Inc Pipeline Products & Ongoing Clinical Trials Overview 207

Multi-Drug Resistance Bacteria Testing Kit – Product Status 207

Multi-Drug Resistance Bacteria Testing Kit – Product Description 207

Optolane Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 208

Molecular Dx – Tuberculosis panel – Product Status 208

Molecular Dx – Tuberculosis panel – Product Description 208

Pathogenica Inc Pipeline Products & Ongoing Clinical Trials Overview 209

Diagnostic Kit – Methicillin Resistant Staphylococcus Aureus – Product Status 209

Diagnostic Kit – Methicillin Resistant Staphylococcus Aureus – Product Description 209

Diagnostic Test – Urinary Tract Infection – Product Status 210

Diagnostic Test – Urinary Tract Infection – Product Description 210

Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 211

Rapid Immunoassay – Gram Negative Bacterial Antigens – Product Status 211

Rapid Immunoassay – Gram Negative Bacterial Antigens – Product Description 211

Pictor Ltd Pipeline Products & Ongoing Clinical Trials Overview 212

PictArray Sepsis ELISA Kit – Product Status 212

PictArray Sepsis ELISA Kit – Product Description 212

PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 213

CARA Salmonella Detection Test – Product Status 213

CARA Salmonella Detection Test – Product Description 213

Presymptom Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 214

Diagnostic Test – Sepsis – Product Status 214

Diagnostic Test – Sepsis – Product Description 214

Presymptom Health Ltd – Ongoing Clinical Trials Overview 215

Diagnostic Test – Sepsis – Study to Evaluate the Efficacy of a Blood Test to Predict Sepsis in Patients 216

Proactive Oral Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 217

CARE Test – Product Status 217

CARE Test – Product Description 217

ProCelo AS Pipeline Products & Ongoing Clinical Trials Overview 218

Diagnostic Kit – Escherichia Coli – Product Status 218

Diagnostic Kit – Escherichia Coli – Product Description 218

Diagnostic Kit – Group B Streptococci – Product Status 219

Diagnostic Kit – Group B Streptococci – Product Description 219

Diagnostic Kit – Haemophilus Influenzae B – Product Status 219

Diagnostic Kit – Haemophilus Influenzae B – Product Description 220

Diagnostic Kit – Mycoplasma Pneumonia – Product Status 220

Diagnostic Kit – Mycoplasma Pneumonia – Product Description 220

Diagnostic Kit – Mycoplasma Urealyticum – Product Status 221

Diagnostic Kit – Mycoplasma Urealyticum – Product Description 221

Diagnostic Kit – Neisseria Meningitidis – Product Status 221

Diagnostic Kit – Neisseria Meningitidis – Product Description 222

Diagnostic Kit – Staphylococcus Aureus – Product Status 222

Diagnostic Kit – Staphylococcus Aureus – Product Description 222

Diagnostic Kit – Streptococcus Pneumoniae – Product Status 223

Diagnostic Kit – Streptococcus Pneumoniae – Product Description 223

Diagnostic Kit – Ureaplasma Urealyticum – Product Status 223

Diagnostic Kit – Ureaplasma Urealyticum – Product Description 224

Promyco Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 225

Mycoplasma Fermentans Detection Kit – Product Status 225

Mycoplasma Fermentans Detection Kit – Product Description 225

Mycoplasma Genitalium Serology Kit – Product Status 226

Mycoplasma Genitalium Serology Kit – Product Description 226

Mycoplasma Hominis Serology Kit – Product Status 226

Mycoplasma Hominis Serology Kit – Product Description 226

Ureaplasma Serology Kit – Product Status 227

Ureaplasma Serology Kit – Product Description 227

Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 228

QIAensemble 400 – Bacterial Vaginosis – Product Status 228

QIAensemble 400 – Bacterial Vaginosis – Product Description 228

QIAensemble 400 – Group B Streptococci – Product Status 229

QIAensemble 400 – Group B Streptococci – Product Description 229

QIAsymphony – ESBL – Product Status 229

QIAsymphony – ESBL – Product Description 230

QIAsymphony – Group B Streptococcal Infections – Product Status 230

QIAsymphony – Group B Streptococcal Infections – Prod

Figures

Bacteriology – Pipeline Products by Stage of Development 27

Bacteriology – Pipeline Products by Segment 28

Bacteriology – Pipeline Products by Territory 29

Bacteriology – Pipeline Products by Regulatory Path 30

Bacteriology – Pipeline Products by Estimated Approval Date 31

Bacteriology – Ongoing Clinical Trials 32

Frequently asked questions

Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Bacteriology Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.